Skip to main content
. 2020 Jul 13;9:e53839. doi: 10.7554/eLife.53839

Figure 1. Technologies for cancer systems immunology.

Figure 1.

Technologies used in cancer systems immunology operate either on bulk tissue samples or single-cell suspensions. Conventional MS, NGS, and imaging platforms do not require tissue dissociation (although histology provides single-cell resolution). Droplet-based microfluidics and mass cytometry, in contrast, require cell suspensions, but generate high-dimensional data for individual cells.